Advertisement
Advertisement
December 23, 2024
Avicenna.AI’s Cina-iPE and Cina-ASPECTS Tools Integrated Into Viz.ai One Platform
December 23, 2024—Viz.ai and Avicenna.AI recently announced that Viz.ai is integrating Avicenna.AI’s Cina-iPE and Cina-ASPECTS tools into the Viz.ai One platform. Viz.ai is focused on artificial intelligence (AI)—powered disease detection and intelligent care coordination. Avicenna.AI is a provider of AI-based medical imaging solutions.
According to the companies, the combination of Avicenna.AI’s two AI-based algorithms with Viz.ai’s care-coordination capabilities provides radiologists and specialists with additional insights from CT scans.
The press release stated that the Cina-ASPECTS tool automatically assesses ASPECTS—the Alberta Stroke Program Early CT Score—from CT brain images, providing an objective and reliable measure of stroke severity. The Cina-iPE tool detects incidental pulmonary embolism during routine CT scans and is intended to address delayed and missed findings.
By combining Avicenna.AI’s technology with Viz.ai One, which facilitates real-time communication and coordination among care teams, clinicians can make faster, more informed decisions about treatment options for patients in need, noted the companies.
Avicenna.AI announced FDA 510(k) clearance for its Cina-iPE and Cina-ASPECTS tools in March 2024.
Advertisement
Advertisement
